Support By : Li-lab
| PATHWAY_NAME | REACTOME_ID | KEGG_ID | DRUG_NAME | PUBCHEM_CID | Datasource |
|---|---|---|---|---|---|
| Huntington's disease | R-HSA-1643685 | 0 | tetryzoline | 5419 | drug-path |
| Olfactory transduction | R-HSA-9751605 | map04740 | tetryzoline | 5419 | drug-path |
| Cell adhesion molecules (CAMs) | R-HSA-1031690 | 0 | tetryzoline | 5419 | drug-path |
| Cell cycle | R-HSA-1640170 | map04110 | tetryzoline | 5419 | drug-path |
| Asthma | R-HSA-444620 | map05310 | tetryzoline | 5419 | drug-path |
| Allograft rejection | R-HSA-9679028 | map05330 | tetryzoline | 5419 | drug-path |
| Type I diabetes mellitus | R-HSA-5683209 | map04940 | tetryzoline | 5419 | drug-path |
| Phosphatidylinositol signaling system | R-HSA-1280215 | map04070 | tetryzoline | 5419 | drug-path |
| Neuroactive ligand-receptor interaction | R-HSA-5632681 | map04080 | tetryzoline | 5419 | drug-path |
| Autoimmune thyroid disease | R-HSA-1643685 | map05320 | tetryzoline | 5419 | drug-path |
| Systemic lupus erythematosus | R-HSA-977105 | map05322 | tetryzoline | 5419 | drug-path |
| Parkinson's disease | R-HSA-1643685 | 0 | tetryzoline | 5419 | drug-path |
| Shigellosis | 0 | map05131 | lactobionic acid | 7314 | drug-path |
| Pathogenic Escherichia coli infection | R-HSA-9609646 | map05130 | lactobionic acid | 7314 | drug-path |
| Adipocytokine signaling pathway | R-HSA-168638 | map04920 | lactobionic acid | 7314 | drug-path |
| Graft-versus-host disease | R-HSA-1643685 | map05332 | lactobionic acid | 7314 | drug-path |
| B cell receptor signaling pathway | R-HSA-983705 | map04662 | lactobionic acid | 7314 | drug-path |
| Autoimmune thyroid disease | R-HSA-1643685 | map05320 | lactobionic acid | 7314 | drug-path |
| Olfactory transduction | R-HSA-9751605 | map04740 | lactobionic acid | 7314 | drug-path |
| Asthma | R-HSA-444620 | map05310 | lactobionic acid | 7314 | drug-path |